Randomized trial of intensive early intervention for children with pervasive developmental disorder - PubMed
Clinical Trial
Randomized trial of intensive early intervention for children with pervasive developmental disorder
T Smith et al. Am J Ment Retard. 2000 Jul.
Erratum in
- Am J Ment Retard 2000 Nov;105(6):508
- Am J Ment Retard 2001 May;106(3):208
Abstract
Young children with pervasive developmental disorder were randomly assigned to intensive treatment or parent training. The intensive treatment group (7 with autism, 8 with pervasive developmental disorder not otherwise specified--NOS) averaged 24.52 hours per week of individual treatment for one year, gradually reducing hours over the next 1 to 2 years. The parent training group (7 with autism, 6 with pervasive developmental disorder NOS) received 3 to 9 months of parent training. The groups appeared similar at intake on all measures; however, at follow-up the intensive treatment group outperformed the parent training group on measures of intelligence, visual-spatial skills, language, and academics, though not adaptive functioning or behavior problems. Children with pervasive developmental disorder NOS may have gained more than those with autism.
Similar articles
-
Fernell E, Hedvall Å, Westerlund J, Höglund Carlsson L, Eriksson M, Barnevik Olsson M, Holm A, Norrelgen F, Kjellmer L, Gillberg C. Fernell E, et al. Res Dev Disabil. 2011 Nov-Dec;32(6):2092-101. doi: 10.1016/j.ridd.2011.08.002. Epub 2011 Sep 15. Res Dev Disabil. 2011. PMID: 21985993 Clinical Trial.
-
Strauss K, Vicari S, Valeri G, D'Elia L, Arima S, Fava L. Strauss K, et al. Res Dev Disabil. 2012 Mar-Apr;33(2):688-703. doi: 10.1016/j.ridd.2011.11.008. Epub 2011 Dec 19. Res Dev Disabil. 2012. PMID: 22188793 Clinical Trial.
-
Stereotypy in young children with autism and typically developing children.
MacDonald R, Green G, Mansfield R, Geckeler A, Gardenier N, Anderson J, Holcomb W, Sanchez J. MacDonald R, et al. Res Dev Disabil. 2007 May-Jun;28(3):266-77. doi: 10.1016/j.ridd.2006.01.004. Epub 2006 Jun 30. Res Dev Disabil. 2007. PMID: 16814515
-
[Clinical features in autism].
Robel L. Robel L. Arch Pediatr. 2009 Nov;16(11):1507-12. doi: 10.1016/j.arcped.2009.07.018. Epub 2009 Sep 3. Arch Pediatr. 2009. PMID: 19733037 Review. French.
-
Eldevik S, Hastings RP, Hughes JC, Jahr E, Eikeseth S, Cross S. Eldevik S, et al. Am J Intellect Dev Disabil. 2010 Sep;115(5):381-405. doi: 10.1352/1944-7558-115.5.381. Am J Intellect Dev Disabil. 2010. PMID: 20687823 Review.
Cited by
-
Rogers SJ, Yoder P, Estes A, Warren Z, McEachin J, Munson J, Rocha M, Greenson J, Wallace L, Gardner E, Dawson G, Sugar CA, Hellemann G, Whelan F. Rogers SJ, et al. J Am Acad Child Adolesc Psychiatry. 2021 Jun;60(6):710-722. doi: 10.1016/j.jaac.2020.06.013. Epub 2020 Aug 24. J Am Acad Child Adolesc Psychiatry. 2021. PMID: 32853704 Free PMC article. Clinical Trial.
-
Wong C, Odom SL, Hume KA, Cox AW, Fettig A, Kucharczyk S, Brock ME, Plavnick JB, Fleury VP, Schultz TR. Wong C, et al. J Autism Dev Disord. 2015 Jul;45(7):1951-66. doi: 10.1007/s10803-014-2351-z. J Autism Dev Disord. 2015. PMID: 25578338 Review.
-
Early pharmacological treatment of autism: a rationale for developmental treatment.
Bethea TC, Sikich L. Bethea TC, et al. Biol Psychiatry. 2007 Feb 15;61(4):521-37. doi: 10.1016/j.biopsych.2006.09.021. Biol Psychiatry. 2007. PMID: 17276749 Free PMC article. Review.
-
Hagopian LP, Kurtz PF, Bowman LG, O'Connor JT, Cataldo MF. Hagopian LP, et al. Child Health Care. 2023;52(1):45-69. doi: 10.1080/02739615.2021.1987237. Epub 2022 Jan 25. Child Health Care. 2023. PMID: 36643575 Free PMC article.
-
Vinen Z, Clark M, Paynter J, Dissanayake C. Vinen Z, et al. J Autism Dev Disord. 2018 May;48(5):1673-1683. doi: 10.1007/s10803-017-3414-8. J Autism Dev Disord. 2018. PMID: 29196863
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources